Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTG P1034: HAART Regimens in HIV-Infected Adolescents
NCT00075907Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir, efavirenz in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2004; status: completed.
02
Drugs
lopinavir + ritonavirefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00075907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075907.